​

Zimmer Biomet (ZBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZBH Stock Forecast

Zimmer Biomet (ZBH) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $108.91, with a high of $130.00 and a low of $93.00. This represents a 25.76% increase from the last price of $86.60.

$85 $95 $105 $115 $125 $135 High: $130 Avg: $108.91 Low: $93 Last Closed Price: $86.6

ZBH Stock Rating

Zimmer Biomet stock's rating consensus is Hold, based on 41 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (43.90%), 20 Hold (48.78%), 3 Sell (7.32%), and 0 Strong Sell (0.00%).

Hold
Total 41 3 20 18 0 Strong Sell Sell Hold Buy Strong Buy

ZBH Price Target Upside V Benchmarks

TypeNameUpside
StockZimmer Biomet25.76%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks20.65%

Price Target Trends

1M3M12M
# Anlaysts3716
Avg Price Target$104.00$105.57$108.88
Last Closing Price$86.60$86.60$86.60
Upside/Downside20.09%21.91%25.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2644181128
Dec, 2546171129
Nov, 2556151128
Oct, 2556151128
Sep, 2556151128
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 09, 2026Bernstein$99.00$94.085.23%14.32%
Jan 09, 2026David RomanGoldman Sachs$93.00$94.08-1.15%7.39%
Jan 05, 2026Evercore ISI$120.00$90.0233.30%38.57%
Dec 16, 2025Jeff JohnsonRobert W. Baird$100.00$92.528.08%15.47%
Nov 05, 2025Rick WiseStifel Nicolaus$110.00$87.9125.13%27.02%
Nov 05, 2025Johnson Rice$112.00$88.0527.20%29.33%
Nov 05, 2025Barclays$105.00$103.181.76%21.25%
Oct 13, 2025Ryan ZimmermanBTIG$122.00$94.7128.81%40.88%
Oct 10, 2025RBC Capital$111.00$95.5316.19%28.18%
Sep 19, 2025Stifel Nicolaus$118.00$100.3717.57%36.26%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 09, 2026BernsteinMarket PerformMarket Performhold
Jan 09, 2026Goldman SachsBuySelldowngrade
Jan 06, 2026Raymond JamesUnderperformMarket Performdowngrade
Jan 05, 2026Evercore ISIPositiveOutperformupgrade
Oct 13, 2025BTIGBuyBuyhold
Aug 08, 2025UBSSellSellhold
Aug 07, 2025Roth CapitalBuyBuyhold
May 06, 2025RBC CapitalOutperformOutperformhold
Apr 14, 2025BTIGBuyBuyhold
Oct 15, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.93$1.39$4.91-----
Avg Forecast$7.17$6.84$7.51$7.98$8.56$9.24$9.99$10.61
High Forecast$7.28$6.90$7.57$8.01$8.82$11.87$10.76$10.73
Low Forecast$7.08$6.75$7.23$7.94$8.44$7.18$9.22$10.43
Surprise %-73.08%-79.68%-34.62%-----

Revenue Forecast

$2B $4B $5B $7B $8B $10B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.83B$6.94B$7.39B$2.02B----
Avg Forecast$7.86B$6.87B$7.38B$7.67B$8.01B$8.38B$8.78B$9.19B
High Forecast$7.95B$6.92B$7.43B$7.68B$8.08B$8.38B$8.81B$9.27B
Low Forecast$7.79B$6.80B$7.24B$7.66B$7.92B$8.37B$8.76B$9.07B
Surprise %-13.16%0.95%0.16%-73.62%----

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$401.60M$231.40M$1.02B-----
Avg Forecast$368.25M$224.98M$1.02B$1.67B$1.81B$2.00B$2.10B$2.22B
High Forecast$475.67M$307.13M$1.40B$1.68B$1.85B$2.49B$2.26B$2.25B
Low Forecast$260.83M$142.84M$651.48M$1.67B$1.77B$1.50B$1.93B$2.19B
Surprise %9.06%2.85%------

ZBH Forecast FAQ

Is Zimmer Biomet stock a buy?

Zimmer Biomet stock has a consensus rating of Hold, based on 41 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 20 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Zimmer Biomet is a neutral investment for most analysts.

What is Zimmer Biomet's price target?

Zimmer Biomet's price target, set by 41 Wall Street analysts, averages $108.91 over the next 12 months. The price target range spans from $93 at the low end to $130 at the high end, suggesting a potential 25.76% change from the previous closing price of $86.6.

How does Zimmer Biomet stock forecast compare to its benchmarks?

Zimmer Biomet's stock forecast shows a 25.76% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (20.65%).

What is the breakdown of analyst ratings for Zimmer Biomet over the past three months?

  • January 2026: 14.29% Strong Buy, 14.29% Buy, 64.29% Hold, 3.57% Sell, 3.57% Strong Sell.
  • December 2025: 13.79% Strong Buy, 20.69% Buy, 58.62% Hold, 3.45% Sell, 3.45% Strong Sell.
  • November 2025: 17.86% Strong Buy, 21.43% Buy, 53.57% Hold, 3.57% Sell, 3.57% Strong Sell.

What is Zimmer Biomet’s EPS forecast?

Zimmer Biomet's average annual EPS forecast for its fiscal year ending in December 2025 is $8.56, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $9.24 in 2026, $9.99 in 2027, and $10.61 in 2028.

What is Zimmer Biomet’s revenue forecast?

Zimmer Biomet's average annual revenue forecast for its fiscal year ending in December 2025 is $8.01B, reflecting a 295.91% increase from the reported $2.02B in 2024. The forecast for 2026 is $8.38B, followed by $8.78B for 2027, and $9.19B for 2028.

What is Zimmer Biomet’s net income forecast?

Zimmer Biomet's net income forecast for the fiscal year ending in December 2025 stands at $1.81B, representing a 0% decrease from the reported $0 in 2024. Projections indicate $2B in 2026, $2.1B in 2027, and $2.22B in 2028.